16.10 USD
↗ 1.17 (7.84%)AT CLOSE (11:59 AM EDT)
Vor Biopharma Inc. Common Stock
VORNASDAQ • USD
15.56
↘ 0.55 (3.39%)
POST MARKET (AS OF 07:44 PM EDT)
Post Market
AS OF 07:44 PM EDT
15.56
↘ 0.55 (3.39%)
Market: CLOSED
Shares of Vor Biopharma Inc. Common Stock (VOR) are trading at $16.10. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (587.1%) and a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Jun 26, 2026.
Open?$15.04
High?$16.28
Low?$14.97
Prev. Close?$14.93
Volume?8.1M
Avg. Volume?1.2M
VWAP?$15.68
Rel. Volume?7.00x
Bid / Ask
Bid?$15.27 × 300
Ask?$16.25 × 300
Spread?$0.98
Midpoint?$15.76
Valuation & Ratios
Market Cap?872.4M
Shares Out?54.2M
Float?29.2M
Float %?70.3%
P/E Ratio?N/A
P/B Ratio?-5.80
EPS?-$16.30
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Themes
Employees
76
Market Cap
809.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-02-05
Address
500 BOYLSTON STREET
BOSTON, MA 02116
Phone: 617-655-6580
BOSTON, MA 02116
Phone: 617-655-6580
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?15
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.28Distress
Confidence?56%Low
Short InterestSqueeze Risk
Short % of Float?20.39%Squeeze Risk
Short Interest?6.0M
Days to Cover?7.1
Free Float29.2M
Avg Daily Volume834.1K
Settlement Date2026-06-15
Financial Health
Current Ratio?31.15Strong
Quick Ratio?31.15Strong
Cash Ratio?10.57Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-5.80CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?587.1%STRONG▾
Peers50
S&P97
ROA?-174.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-150651000
Enterprise Value?$702.5M
Fundamentals ratios updated end of day